Indication
Long-chain fatty acid oxidation disorder
A long-chain fatty acid oxidation disorder is a rare, autosomal recessive inborn error of metabolism caused by enzyme deficiencies in the mitochondrial transport or beta-oxidation of long-chain fatty acids. Read more about Long-chain fatty acid oxidation disorder
1 drugs 1 manufacturers
Drugs that treat it
Common Long-chain fatty acid oxidation disorder therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA long-chain fatty acid oxidation disorder is a rare, autosomal recessive inborn error of metabolism caused by enzyme deficiencies in the mitochondrial transport or beta-oxidation of long-chain fatty acids.
This metabolic block impairs cellular energy production from lipids during periods of prolonged fasting, acute illness, or sustained physical exertion.
It predominantly affects high-energy organ systems across neonatal, pediatric, and adult populations, primarily involving cardiac tissue, skeletal muscle, and the liver.
Pathophysiologically, the failure to generate downstream acetyl-CoA and ketone bodies triggers severe hypoketotic hypoglycemia, hyperammonemia, hepatic dysfunction, hypertrophic or dilated cardiomyopathy, and recurrent rhabdomyolysis.
- chop.edu
A long-chain fatty acid oxidation disorder is a rare, autosomal recessive inborn error of metabolism caused by enzyme deficiencies in the mitochondrial transport or beta-oxidation of long-chain fatty acids This metabolic block impairs cellular energy production from lipids during periods of prolonged fasting, acute illness, or sustained physical exertion Pathophysiologically, the failure to generate downstream acetyl-CoA and ketone bodies triggers severe hypoketotic hypoglycemia, hyperammonemia,...
- nih.gov
A long-chain fatty acid oxidation disorder is a rare, autosomal recessive inborn error of metabolism caused by enzyme deficiencies in the mitochondrial transport or beta-oxidation of long-chain fatty acids This metabolic block impairs cellular energy production from lipids during periods of prolonged fasting, acute illness, or sustained physical exertion Pathophysiologically, the failure to generate downstream acetyl-CoA and ketone bodies triggers severe hypoketotic hypoglycemia, hyperammonemia,...
- nih.gov
This metabolic block impairs cellular energy production from lipids during periods of prolonged fasting, acute illness, or sustained physical exertion
- nih.gov
It predominantly affects high-energy organ systems across neonatal, pediatric, and adult populations, primarily involving cardiac tissue, skeletal muscle, and the liver
- nih.gov
It predominantly affects high-energy organ systems across neonatal, pediatric, and adult populations, primarily involving cardiac tissue, skeletal muscle, and the liver
- nih.gov
Pathophysiologically, the failure to generate downstream acetyl-CoA and ketone bodies triggers severe hypoketotic hypoglycemia, hyperammonemia, hepatic dysfunction, hypertrophic or dilated cardiomyopathy, and recurrent rhabdomyolysis
Personalize your experience
Follow Long-chain fatty acid oxidation disorder and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.